Certain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed. MASTER SERVICES AGREEMENT between SAMSUNG BIOLOGICS CO., LTD. and CYTODYN INC.Master Services Agreement • August 14th, 2019 • CytoDyn Inc. • Pharmaceutical preparations • New York
This Master Services Agreement (this “MSA”) is made and entered into as of the date of last signature below (the “Effective Date”) by and between CytoDyn Inc., a Delaware corporation having its principal place of business at 1111 Main Street, Suite 660, Vancouver, WA 98660 (“Client”), and Samsung BioLogics Co., Ltd., a company with offices at 300, Songdo bio-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea (“SBL”). Client and SBL are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Certain identified information has been excluded because it is both not material and would likely cause competitive harm if publicly disclosed. SAMSUNG BIOLOGICS CO., LTD. PRODUCT SPECIFIC AGREEMENT COMMERCIAL DRUG SUBSTANCEProduct Specific Agreement • August 14th, 2019 • CytoDyn Inc. • Pharmaceutical preparations
